Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas

Potential for Differentiation of Pseudoprogression From True Tumor Progression With Dynamic Susceptibility-Weighted Contrast-Enhanced Magnetic Resonance Imaging Using Ferumoxytol vs. Gadoteridol: A Pilot Study

(2010) Seymur Gahramanov et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

(2010) Patrick Y. Wen et al.   JOURNAL OF CLINICAL ONCOLOGY

Pediatric High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas

(2009) Jason Fangusaro   JOURNAL OF CHILD NEUROLOGY

Brain Tumor Imaging in Clinical Trials

(2008) J.W. Henson et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Inter-observer variability in the measurement of diffuse intrinsic pontine gliomas

(2008) Robert M. Hayward et al.   JOURNAL OF NEURO-ONCOLOGY

Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas

(2008) Hideho Okada et al.   JOURNAL OF NEURO-ONCOLOGY

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

(2008) Dieta Brandsma et al.   LANCET ONCOLOGY

Phase II preradiation R115777 (tipifarnib) in newly diagnosed GBM with residual enhancing disease

(2008) Robert Lustig et al.   NEURO-ONCOLOGY

Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma

(2008) Daphne A. Haas-Kogan et al.   NEURO-ONCOLOGY

Response criteria for glioma

(2008) A Gregory Sorensen et al.   Nature clinical practice. Oncology